Newsroom

Back
  • Newsroom
    • Research Newsroom
    • Contact a Media Specialist
    • B-roll Footage
    • Embargo Policy
    • Media Visitation Policy
    • Request to Film on Campus
    • Style Guide
    • Philanthropy Newsroom
    • Archived News

    MD Anderson and UICC collaborate to improve women's cancer care

    October 08, 2024

    The University of Texas MD Anderson Cancer Center today announced an agreement to become a Women’s Cancer Partner with the Union for International Cancer Control (UICC), marking a significant collaboration to improve breast and cervical cancer care worldwide. In this capacity, MD Anderson will actively participate in UICC’s initiatives aimed at addressing women’s cancers, with a focus on strategic development, knowledge-sharing and global...

    Read More

    Adding metastasis-directed radiation therapy boosts progression-free survival in metastatic pancreatic cancer

    BY Rolaynne Kimmons

    August 05, 2024

    Researchers from The University of Texas MD Anderson Cancer Center demonstrated that adding metastasis-directed radiation therapy...

    Read More

    MD Anderson expands global oncology efforts through new agreement with Zambia Ministry of Health

    BY Rolaynne Kimmons

    July 18, 2024

    The University of Texas MD Anderson Cancer Center today announced the further expansion of its global oncology efforts by signing a memorandum...

    Read More

    MD Anderson celebrates the life and legacy of V. Craig Jordan, Ph.D.

    June 12, 2024

    Pharmacologist V. Craig Jordan, Ph.D., a professor of Breast Medical Oncology and Molecular and Cellular Oncology at The University of Texas MD Anderson Cancer Center who discovered Selective Estrogen Receptor Modulators (SERMs) and developed breakthrough breast cancer treatments, died June 9, 2024, at his home in Houston. He was 76 years old.

    Known as the “father of tamoxifen,” Jordan showed that the drug, originally created to...

    Read More

    ASCO: Novel targeted cancer therapies demonstrate activity and safety in metastatic solid tumors

    BY Rolaynne Kimmons

    June 01, 2024

    ABSTRACTS: 3000 and 3005

    Two early-phase clinical trials presented at the 2024 American Society of Clinical Oncology (ASCO) Annual...

    Read More

    MD Anderson and Pan American Health Organization join forces to support cancer prevention and control in the Americas

    BY Rolaynne Kimmons

    May 01, 2024

    The University of Texas MD Anderson Cancer Center and the Pan American Health Organization (PAHO) today announced the signing of an agreement...

    Read More

    MD Anderson and RUSH Unveil RUSH MD Anderson Cancer Center

    BY Rolaynne Kimmons

    April 26, 2024

    The University of Texas MD Anderson Cancer Center and RUSH University System for Health today announced a partnership to create RUSH MD Anderson...

    Read More

    Radiation before mastectomy cuts time delays for reconstructive surgery in breast cancer patients

    BY Rolaynne Kimmons

    April 05, 2024

    Researchers at The University of Texas MD Anderson Cancer Center showed that altering the sequence of breast cancer treatment to administer...

    Read More

    AACR: MD Anderson's Padmanee Sharma elected Fellow of the AACR Academy

    BY Rolaynne Kimmons

    April 03, 2024

    Padmanee Sharma, M.D., Ph.D., associate vice president of Immunobiology, professor of Genitourinary Medical Oncology and Immunology, and director...

    Read More

    MD Anderson designated IAEA Collaborating Centre to focus on improving radiation, radiology and nuclear medicine worldwide

    BY Rolaynne Kimmons

    January 30, 2024

    The University of Texas MD Anderson Cancer Center today announced the signing of an agreement with the International Atomic Energy Agency...

    Read More
    More

    Help #EndCancer

    Give Now

    Your gift will help make a tremendous difference.
    Donate

    Donate Blood

    Our patients depend on blood and platelet donations.

    Make an appointment

    Shop UT MD Anderson

    Show your support for our mission through branded merchandise. 

    View products
    Subscribe to our Cancerwise newsletter
    UT MD Anderson logoUT MD Anderson logo
    • Explore
    • Patients & Family
    • Prevention & Screening
    • Donors & Volunteers
    • For Physicians
    • Research
    • Education & Training
    • Clinical Trials
    • Languages
    • About
    • About UT MD Anderson
    • Careers
    • Blog
    • Newsroom
    • Editorial Standards
    • For Employees
    • Merchandise
    • Title IX Reporting (Sexual Misconduct)
    • Price Transparency
    • Finding Your Way
    • Our Doctors
    • Locations
    • Directions
    • Sitemap
    • DIGITAL ACCESSIBILITY
    • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
    • GET IN TOUCH
    • Call
      1-877-632-6789
    • Ask a question
    • Stay Connected
    • Cancerwise Podcast
    • More
    • Website Privacy Policy
    • Legal Statement & Policies
    • Reports to the State
    • Emergency Alert Information
    • State of Texas Links
    • Our Cancer Network
    • Vendors & Suppliers
    UT MD Anderson logo
    The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

    © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

    Top